Another potent drug-target protein is RET, controlling five oncoproteins (MAPK3, PLK1, OPTN, PTTG1, CDH1) in the ovarian cancer network, Fig. 4 and Table 4. The gene discussed is RET; the disease is ovarian carcinoma.